TRT / RTR Design [RSABE / ABEL]

posted by mittyri  – Russia, 2017-05-02 20:38 (2981 d 20:01 ago) – Posting: # 17295
Views: 10,278

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

❝ The appropriate sample size must be.

❝ Alpha correction.

what did you mean here?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,679 registered users;
61 visitors (0 registered, 61 guests [including 7 identified bots]).
Forum time: 16:40 CEST (Europe/Vienna)

Fools with Tools Are Still Fools!    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5